When does neuromodulation become the preferred intervention?

For a significant percentage of patients, even a "successful" surgery does not resolve sciatic pain, leading to Failed Back Surgery Syndrome. In these cases, Spinal Cord Stimulation (SCS) and Dorsal Root Ganglion (DRG) stimulation offer a way to mask pain signals before they reach the brain.

Why is the Chronic Sciatica Neuromodulation Market expanding?

Technology has evolved from "paresthesia" (tingling) to "sub-perception" therapy, where patients feel no sensation other than pain relief. The Chronic Sciatica Neuromodulation Market is seeing a CAGR boost as 2024 devices become smaller, rechargeable-free, and MRI-compatible for 2025.

The shift toward Closed-Loop Stimulators

Current 2024 systems are "closed-loop," meaning they sense the electrical activity of the spinal cord and adjust the stimulation intensity automatically as the patient moves, coughs, or changes position. This level of automation significantly improves the patient's quality of life.

Market Outlook for 2024/2025

By 2025, neuromodulation will be positioned as an alternative to "revision surgery." Clinicians are increasingly recommending a stimulation trial before undergoing a second or third discectomy, which often has diminishing returns for the patient.

Author: Sofiya Sanjay

Designation: Healthcare Research Consultant, Market Research Future

About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Our studies across products, technologies, applications, end users, and global to country-level segments help decision-makers see more, know more, and do more.

Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | +44 1720 412 167 (UK) | +91 2269738890 (APAC) | info@marketresearchfuture.com